| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Barbara R Sommer, Lowell C Wise, Helena C Kraeme. Is dopamine administration possibly a risk factor for delirium? Critical care medicine. vol 30. issue 7. 2002-09-17. PMID:12130971. |
we explored the possibility that the administration of intravenous dopamine increases the risk for delirium as manifested by need for haloperidol. |
2002-09-17 |
2023-08-12 |
Not clear |
| Huei-Ching Hsieh, Hui-Yun Li, Ming-Yu Lin, Ya-Fen Chiou, Shao-Yun Lin, Chung-Hung Wong, Jin-Chung Che. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats. Synapse (New York, N.Y.). vol 45. issue 4. 2002-09-13. PMID:12125044. |
to determine if d(2) dopamine receptor-mediated nuclear signaling is altered during the development of amphetamine sensitization, we examined the expression of immediate-early gene (ieg) products, fos, jun, and fos-related antigen (fra), in both controls and amphetamine-sensitized rats after a challenge with the d(2) antagonist haloperidol. |
2002-09-13 |
2023-08-12 |
rat |
| Vincenzo Di Matteo, Marisa Cacchio, Camillo Di Giulio, Giuseppe Di Giovanni, Ennio Esposit. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Pharmacology, biochemistry, and behavior. vol 71. issue 4. 2002-09-11. PMID:11888552. |
therefore, the effects of clozapine (5 mg/kg ip), risperidone (0.08 mg/kg ip) and of the typical antipsychotic haloperidol (0.1 mg/kg ip) were studied on the extracellular concentration of dopamine (da) in the nucleus accumbens of chloral hydrate-anesthetized rats, using intracerebral microdialysis. |
2002-09-11 |
2023-08-12 |
human |
| Carlo Cavallotti, Federica Nuti, Paolo Bruzzone, Massimo Mancon. Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clinical and experimental pharmacology & physiology. vol 29. issue 5-6. 2002-08-29. PMID:12010185. |
the greater sensitivity to displacement by amisulpride, bromocriptine, domperidone, haloperidol, raclopride and l-sulpiride than to displacement by n-propyl-norapomorphine, quinpirole and clozapine suggests that the binding sites observed in these experiments are likely to belong to the dopamine d2 receptor subtype. |
2002-08-29 |
2023-08-12 |
rat |
| N Hussain, B A Flumerfelt, N Rajakuma. Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. Neuroscience. vol 112. issue 2. 2002-08-29. PMID:12044460. |
it is generally believed that haloperidol exerts its motor side effects and therapeutic effects mainly by antagonizing dopamine d(2) receptors in the striatum and the nucleus accumbens, respectively. |
2002-08-29 |
2023-08-12 |
Not clear |
| Ryan K Bachtell, Natalia O Tsivkovskaia, Andrey E Ryabini. Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms. The Journal of pharmacology and experimental therapeutics. vol 302. issue 2. 2002-08-29. PMID:12130710. |
in addition, 10 mg/kg 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)4,5-dihydro-1h-imidazole (rx 821002), an alpha(2a/d)-adrenoceptor antagonist, and 20 mg/kg haloperidol, a dopamine antagonist, also block alcohol-induced c-fos expression in edinger-westphal neurons. |
2002-08-29 |
2023-08-12 |
Not clear |
| Yosuke Uchitom. [Management of psychiatric symptoms in cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy. vol 29. issue 7. 2002-08-09. PMID:12146016. |
haloperidol, a neuroleptic agent (antipsychotic) that is a potent dopamine blocker, is the drug of choice for the treatment of delirium in persons with cancer because of the low incidence of related cardiovascular and anticholinergic effects. |
2002-08-09 |
2023-08-12 |
Not clear |
| Gurpreet Kaur, Shrinivas K Kulkarn. Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 2. 2002-07-22. PMID:11817504. |
the aim of this study was to examine the effects of different doses of typical antipsychotics, chlorpromazine (0.25-1 mg/kg) and haloperidol (0.25-1 mg/kg), and atypical antipsychotics, clozapine (0.5-2 mg/kg), olanzapine (0.25-1 mg/kg), risperidone (0.5-2 mg/kg), sulpiride (10-40 mg/kg) and dopamine d1 antagonist, sch 23390 (0.25-1 mg/kg) on feeding behavior at different time intervals after acute administration. |
2002-07-22 |
2023-08-12 |
mouse |
| Eero Pekkone, Jyrki Hirvonen, Jyrki Ahveninen, Seppo Kähkönen, Seppo Kaakkola, Juha Huttunen, Iiro P Jääskeläine. Memory-based comparison process not attenuated by haloperidol: a combined MEG and EEG study. Neuroreport. vol 13. issue 1. 2002-07-18. PMID:11924884. |
we used simultaneously magnetoencephalography and electroencephalography to investigate, whether a single dose of haloperidol, a dopamine d2-receptor antagonist, modulates preattentive auditory processing using a randomized, double-blind, placebo-controlled crossover design. |
2002-07-18 |
2023-08-12 |
Not clear |
| Moshe Rehavi, Netta Roz, Abraham Weizma. Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 12. issue 3. 2002-07-16. PMID:12007678. |
we compared the effect of chronic clozapine and haloperidol treatment on the expression of rat brain vesicular monoamine transporter (vmat(2)) as well as on the membranal presynaptic transporters for serotonin, dopamine and noradrenaline. |
2002-07-16 |
2023-08-12 |
rat |
| I Gil-ad, B Shtaif, R Shiloh, A Weizma. Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms. Cellular and molecular neurobiology. vol 21. issue 6. 2002-06-25. PMID:12043843. |
perphenazine, haloperidol, clozapine, sulpiride, and risperidone (10-100 microm) were administered, either alone or combined with dopamine, to primary mouse neuronal or intact brain culture and to a human neuroblastoma (nb) cell line (sk-n-sh). |
2002-06-25 |
2023-08-12 |
mouse |
| Fernando Catalina, Leon Milewich, William Frawley, Vinay Kumar, Michael Bennet. Decrease of core body temperature in mice by dehydroepiandrosterone. Experimental biology and medicine (Maywood, N.J.). vol 227. issue 6. 2002-06-21. PMID:12037127. |
because serotonin and dopamine can regulate (decrease) body temperature, we treated mice with haloperidol (dopamine receptor antagonist), 5,7-dihydroxytryptamine (serotonin production inhibitor), or ritanserin (serotonin receptor antagonist) prior to injection of dhea. |
2002-06-21 |
2023-08-12 |
mouse |
| J E Belforte, C Magariños-Azcone, I Armando, W Buño, J H Paz. Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum. Parkinsonism & related disorders. vol 8. issue 1. 2002-06-20. PMID:11472878. |
intrastriatal injections of haloperidol (5microg/microl), an antagonist of dopamine d(2) receptors, or the sodium channel blocker lidocaine (40microg/microl), were given in order to compare their effects to those observed with flunarizine. |
2002-06-20 |
2023-08-12 |
rat |
| Stacy L Sell, Charles P Franc. Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys. The Journal of pharmacology and experimental therapeutics. vol 301. issue 3. 2002-06-19. PMID:12023543. |
in contrast, the dopamine antagonist haloperidol shifted the naltrexone dose-effect curve 5-fold leftward. |
2002-06-19 |
2023-08-12 |
monkey |
| J Amiel Rosenkranz, Anthony A Grac. Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning. Nature. vol 417. issue 6886. 2002-06-10. PMID:12015602. |
the dopamine antagonist haloperidol blocked the psp enhancement and associated increased neuronal excitability, without reversing previous conditioning. |
2002-06-10 |
2023-08-12 |
rat |
| Marcus Dietrich, Michael H Hofmann, Horst Bleckman. Effects of dopaminergic drugs and telencephalic ablation on eye movements in the goldfish, Carassius auratus. Brain research bulletin. vol 57. issue 3-4. 2002-05-20. PMID:11922996. |
the effect of the dopamine agonist apomorphine and the antagonist haloperidol on eye movements was tested in normal and telencephalon ablated goldfish. |
2002-05-20 |
2023-08-12 |
Not clear |
| M Srisurapanont, P Kittiratanapaiboon, N Jarusuraisi. Treatment for amphetamine psychosis. The Cochrane database of systematic reviews. issue 4. 2002-04-19. PMID:11687172. |
it has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis. |
2002-04-19 |
2023-08-12 |
Not clear |
| B Weber, E Schlicke. Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors. Fundamental & clinical pharmacology. vol 15. issue 6. 2002-04-19. PMID:11860527. |
the inhibitory effect of a submaximally active concentration of b-ht 920 was counteracted by the dopamine d(2/3) antagonist haloperidol but not affected by the alpha(2)-adrenoceptor antagonist phentolamine. |
2002-04-19 |
2023-08-12 |
Not clear |
| Hitoshi Nakano, Shin-Da Lee, Gaspar A Farka. Dopaminergic modulation of ventilation in obese Zucker rats. Journal of applied physiology (Bethesda, Md. : 1985). vol 92. issue 1. 2002-04-10. PMID:11744639. |
ventilation (ve) was measured by the barometric technique during hyperoxic (100% o(2)), normoxic (21% o(2)), hypoxic (10% o(2)), and hypercapnic (7% co(2)) exposures after the administration of vehicle (control), haloperidol [hal, 1 mg/kg, a central and peripheral dopamine (da) receptor antagonist], or domperidone (dom, 0.5 mg/kg, a peripheral da receptor antagonist). |
2002-04-10 |
2023-08-12 |
rat |
| Pierre O Fernagut, Elsa Diguet, Bertrand Labattu, François Tiso. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. Journal of neuroscience methods. vol 113. issue 2. 2002-04-05. PMID:11772434. |
dopamine depletion by reserpine and striatal dopamine receptor blockade by haloperidol resulted in reduced mean stride length in four limbs. |
2002-04-05 |
2023-08-12 |
mouse |